SciTide
Pharmaceutical Manufacturing
2 Shaker Rd
10 employees
- Employees
- 10
- Contacts
- 3
- Emails
- 3
- Phones
- 1
SciTide Overview
- Headquarters
- 2 Shaker Rd
- Website
- www.scitide.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 10
- Founded
- 2023
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
About SciTide
SciTide's custom peptide synthesis platform is built on flexible, automated, and robust manufacturing processes that leverage internally designed AI tools to aid in the evaluation and production of custom synthetic peptides. We pride ourselves on delivering peptides of exceptional purity to meet the diverse needs of the scientific community. We understand every project has unique requirements and offer flexibility with-in our processes to ensure each peptide is tailored to our customers unique requirements.
SciTide Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
SciTide Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Samuel Massoni | Founding Partner, Scitide, New England |
View
|
|
| Brandon Smith | Founder and CEO at Scitide | Greater Boston, United States |
Email
Phone
|
| Ashley Wing | Final Formulation Coordinator @ Scitide | United States |
Email
|
| Jason Tovar | Graduate of Biology at Fitchburg State | Clinton, Massachusetts, United States |
Email
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Associate / junior
1 profile
Compare Similar Companies to SciTide
NEP Group, Inc.
Broadcast Media Production And Distribution
Biosynth
Pharmaceutical Manufacturing
Modern Heating & Air Conditioning
Facilities Services
Iota Omega Epsilon
Professional Organizations
FFR, Inc.
Financial Services
Bait & Hook
Restaurants
OWN IT Summit
Philanthropy
US HUPO
Non-Profit Organizations
TIDEtalks
Biotechnology Research
BareVista
Venture Capital And Private Equity Principals